TL1A is shown to stimulate both Th1 and Th17 responses, and this new cytokine axis has been investigated in chronic inflammatory disorders such as rheumatoid arthritis or inflammatory bowel disease (IBD) [20,22,23]. This evidence concerns the gene TNFSF15 and inflammatory bowel disease.